Mole Checker Skin Dermatology

Skinvision Melanoma Analyzer

Veröffentlicht von: Jose Bello

Beschreibung

Mole Checker uses artificial intelligence and large amounts of data to improve your health and wellness.
Mole Checker is a groundbreaking application designed to assist you in taking care of your health and wellness, with a focus on dermatology and skin cancer prevention. Health is our most valuable asset, and taking care of it is essential for complete well-being. Utilizing artificial intelligence and computer vision, this application allows you to perform quick and easy checks of moles and skin lesions to determine whether they are benign or malignant. The application has been trained with thousands of confirmed melanoma images and uses an advanced AI algorithm to compare your images with this dataset, helping you identify potential skin cancer risks and concerning skin rash.
A skin cancer self-exam is used to identify suspicious moles or lesions that may be cancer or growths that may develop into skin cancer (precancers). Individuals who are at a high risk of skin cancer are encouraged to perform frequent skin self-exams. It is explained, within the app, how to track and review the moles and lesions.
When it comes to Skin Cancer, there is a lot of information out there and it's very hard to be sure you're making the right decisions. That's where this app becomes more and more useful. By using Artificial Intelligence, we can help take some of the guesswork out of your condition.
One of the key features of Mole Checker is its ability to track your moles over time. You can take photos of your mole and skin lesions, and the application will securely store them, allowing you to compare them with previous images, as you can generate a video progress. This will help you identify any changes in the size, shape, or color of your moles, which is crucial for early detection of skin cancer and maintaining optimal health.
Mole Checker aims to reduce the alarming statistics of skin cancer. According to the Skin Cancer Foundation, two people die every hour from skin cancer in the United States alone. In the U.S., over 9,500 people are diagnosed with skin cancer every day.
Source datasets:
SIIM is joined by the International Skin Imaging Collaboration (ISIC), an international effort to improve melanoma diagnosis. The ISIC Archive contains the largest publicly available collection of quality-controlled dermoscopic images of skin lesions. There are more than 33000 images analyzed to create this app.
MEDICAL ADVICE DISCLAIMER
This application and its usage are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Any results from this application are purely for informative purposes and should not be treated as medical advice. You understand and acknowledge that all users of this application are responsible for their own medical care, treatment, and oversight. All of the content provided in the application is for informational purposes only and DOES NOT CONSTITUTE THE PROVIDING OF MEDICAL ADVICE and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment. The content is not intended to establish a standard of care to be followed by a user of the application. You understand and acknowledge that you should always seek the advice of your physician or other qualified health provider with any questions or concerns you may have regarding your health. Medical information changes constantly. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of this application. If you think you may have a medical emergency, call your doctor or go to the emergency department. This app does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on this application.
Contact: [email protected]
Ausblenden Mehr anzeigen...

Screenshots

Mole Checker Skin Dermatology Häufige Fragen

  • Ist Mole Checker Skin Dermatology kostenlos?

    Ja, Mole Checker Skin Dermatology ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist Mole Checker Skin Dermatology seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Mole Checker Skin Dermatology?

    Mole Checker Skin Dermatology ist kostenlos.

  • Wie hoch ist der Umsatz von Mole Checker Skin Dermatology?

    Um geschätzte Einnahmen der Mole Checker Skin Dermatology-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung

1 von 5

1 Bewertungen in Israel

5 star
0
4 star
0
3 star
0
2 star
0
1 star
1
Bewertungsverlauf

Mole Checker Skin Dermatology Bewertungen

Keine Bewertungen in Israel
Die App hat noch keine Bewertungen in Israel.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
Diagramm
Kategorie
Rang
Top Bezahlt
36
Top Bezahlt
61
Top Bezahlt
89
Top Bezahlt
90
Top Bezahlt
93

Schlüsselwörter

Mole Checker Skin Dermatology Konkurrenten

Mole Checker Skin Dermatology Installationen

Letzte 30 Tage

Mole Checker Skin Dermatology Umsatz

Letzte 30 Tage

Mole Checker Skin Dermatology Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Mole Checker Skin Dermatology mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.

App-Informationen

This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.